Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

astrazeneca_plaque_web

AstraZeneca gets green light for £27.5bn Alexion acquisition

July 14, 2021 Research and Development

AstraZeneca has been given the green light of its $39 billion buyout of US-based rare diseases business Alexion by the …
News
nhs_old_hospital_1

NHS: Cancer backlog to be cleared by March 2022

July 14, 2021 Research and Development

NHS chiefs have announced plans to clear the backlog of cancer patients caused by the pandemic by March 2022. Due …
News

Half the world oblivious to link between oral hygiene and overall health

July 14, 2021 Research and Development

A new study from GSK’s consumer healthcare business and Ipsos has shown that half of the world (49%) doesn’t know …
News

Mass COVID testing reduces cases by a fifth study shows

July 7, 2021 Research and Development COVID-19 testing, COVID-19. testing, lateral flow tests, liverpool

A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …
News
subcutaneous-injection-tn

First ex vivo human skin platform investigating ISR launched

July 7, 2021 Research and Development

Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …
News

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021 Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …
News
johnson_and_johnson_jj

EU orders nearly 40 million more J&J COVID vaccines

July 7, 2021 Research and Development

The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …
News
boehringer_biberach_germany_copy

Breakthrough heart failure drug meets primary endpoint

July 7, 2021 Research and Development

The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …
News

PrecisionLife appoints Ray Pawlicki as Executive Chair to the board of directors

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.Widely …
Appointment
golo_von_basum

New Chief Operating Officer for Dutch MedTech STENTiT

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medical device company STENTiT has appointed Dr Golo von Basum as its Chief Operating Officer.He will be responsible for the …
Appointment
christian_dillon

Christian Dillon announced as Vice President of Biology at PhoreMost

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …
Appointment
serap_becker

Ashfield Engage appoints new Head of Patient Solutions

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …
Appointment
pers

Personalised medicine in oncology: Where are we now?

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Feature

Novartis appoints Alessandra Dorigo as General Manager

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Appointment
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026